PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Yes, totally agree with that assessment. First to market, with a...

  1. 293 Posts.
    lightbulb Created with Sketch. 110
    Yes, totally agree with that assessment. First to market, with a two or three year head start, will leave us very well placed, and hopefully very rich too
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.